TY  - JOUR
AU  - Onecha de La Fuente, Maria Esther
AU  - Linares Gomez, Maria
AU  - Rapado, Inmaculada
AU  - Ruiz-Heredia, Yanira
AU  - Martinez-Sanchez, Pilar
AU  - Cedena, Teresa
AU  - Pratcorona, Marta
AU  - Perez Oteyza, Jaime
AU  - Herrera, Pilar
AU  - Barragan, Eva
AU  - Montesinos, Pau
AU  - Garcia Vela, Jose Antonio
AU  - Magro, Elena
AU  - Anguita, Eduardo
AU  - Figuera, Angela
AU  - Riaza, Rosalia
AU  - Martinez-Barranco, Pilar
AU  - Sanchez-Vega, Beatriz
AU  - Nomdedeu, Josep
AU  - Gallardo, Miguel
AU  - Martínez-López J, Joaquin
AU  - Ayala, Rosa
PY  - 2018
DO  - 10.3324/haematol.2018.194712
SN  - 0390-6078
UR  - http://hdl.handle.net/20.500.12105/6553
AB  - A high proportion of patients with acute myeloid leukemia who achieve minimal residual disease (MRD) negative status ultimately relapse because a fraction of pathological clones remains undetected by standard methods. We designed and validated a...
LA  - eng
KW  - Acute Myeloid Leukemia
KW  - Minimal Residual Disease
KW  - Sequencing
TI  - Novel deep targeted sequencing method for minimal residual disease monitoring in acute myeloid leukemia
TY  - journal article
ER  -